Hikal P/B Ratio
Hikal (HIKAL) P/B ratio is 2.42 (Moderate), book value per share ₹479.60 vs Healthcare average P/B of -0.01 — High - Premium to book value, growth expectations or asset-light model. For live price, earnings yield and the full fundamental profile, see Hikal share price screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
HIKAL P/B Ratio — Valuation Insights & Book Value Analysis
Hikal price-to-book ratio interpretation, valuation status and historical context — current P/B 2.42 (Moderate). Read Hikal dividend policy for the complete payout history and dividend yield track record.
- Current PB is 259.1% above historical average
- Trading at premium to sector average PB of -0.01
Hikal P/B Ratio Historical Trend
HIKAL annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore HIKAL value investing to estimate fundamental worth using multiple valuation models.
HIKAL Historical P/B Ratio — Book Value Per Share & Year-End Price
Hikal annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.47 | ₹479.6 | ₹226.04 | ₹1,199 | Low |
| 2025 | 0.45 | ₹504.8 | ₹226.83 | ₹1,262 | Low |
| 2024 | 0.82 | ₹475.2 | ₹390.50 | ₹1,188 | Low |
| 2023 | 0.67 | ₹453.6 | ₹303.95 | ₹1,134 | Low |
| 2022 | 0.96 | ₹427.2 | ₹410.10 | ₹1,068 | Low |
HIKAL vs Healthcare Peers — P/B Ratio Comparison
Hikal P/B 2.42 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |